PA8562701A1 - Metodos y composiciones para el tratamiento de patologias respiratorias - Google Patents

Metodos y composiciones para el tratamiento de patologias respiratorias

Info

Publication number
PA8562701A1
PA8562701A1 PA20028562701A PA8562701A PA8562701A1 PA 8562701 A1 PA8562701 A1 PA 8562701A1 PA 20028562701 A PA20028562701 A PA 20028562701A PA 8562701 A PA8562701 A PA 8562701A PA 8562701 A1 PA8562701 A1 PA 8562701A1
Authority
PA
Panama
Prior art keywords
compositions
methods
treatment
pathologies
respiratory pathologies
Prior art date
Application number
PA20028562701A
Other languages
English (en)
Inventor
Lionel Bueno
Original Assignee
Rytek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0116706A external-priority patent/FR2833839A1/fr
Application filed by Rytek filed Critical Rytek
Publication of PA8562701A1 publication Critical patent/PA8562701A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

LA PRESENTE SOLICITUD SE REFIERE A COMPOSICIONES Y METODOS PARA TRATAR PATOLOGIAS RESPIRATORIAS. TAMBIEN SE REFIERE A COMPOSICIONES Y METODOS QUE PERMITEN LA REGULACION DE LA PERMEABILIDAD PARACELULAR DEL EPITELIO PULMONAR. LAS COMPOSICIONES Y LOS METODOS DE LA INVENCION SE BASAN, EN PARTICULAR, EN EL USO DE AGENTES O CONDICIONES QUE MODULAN LA TENSION DEL CITOESQUELETO DE LAS CELULAS EPITELIALES PULMONARES, EN PARTICULAR, LOS ENTEROCITOS. LA INVENCION PUEDE USARSE PARA EL TRATAMIENTO PREVENTIVO O CURATIVO DE VARIAS PATOLOGIAS, COMO EL ASMA, LAS ALERGIAS, LAS ENFERMEDADES OBSTRUCTIVAS, ETC., EN MAMIFEROS, PARTICULARMENTE EN SERES HUMANOS.
PA20028562701A 2001-12-21 2002-12-20 Metodos y composiciones para el tratamiento de patologias respiratorias PA8562701A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116706A FR2833839A1 (fr) 2001-12-21 2001-12-21 Methodes et compositions pour le traitement de pathologies respiratoires
FR0208606A FR2833840B1 (fr) 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires

Publications (1)

Publication Number Publication Date
PA8562701A1 true PA8562701A1 (es) 2004-02-16

Family

ID=26213306

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20028562701A PA8562701A1 (es) 2001-12-21 2002-12-20 Metodos y composiciones para el tratamiento de patologias respiratorias

Country Status (12)

Country Link
US (2) US20030125321A1 (es)
EP (1) EP1455767A2 (es)
AR (1) AR038042A1 (es)
AU (1) AU2002364679A1 (es)
CA (1) CA2470442A1 (es)
FR (1) FR2833840B1 (es)
PA (1) PA8562701A1 (es)
PE (1) PE20030853A1 (es)
SV (1) SV2003001439A (es)
TW (1) TW200305447A (es)
UY (1) UY27589A1 (es)
WO (1) WO2003053422A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
TWI379839B (en) * 2003-12-17 2012-12-21 Wyeth Llc Aβ immunogenic peptide carrier conjugates and methods of producing same
AU2005277203A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
FR2879100B1 (fr) * 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
EP2111863B1 (en) 2005-10-26 2012-03-28 Asahi Kasei Pharma Corporation Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
WO2008073627A2 (en) * 2006-11-03 2008-06-19 Alba Therapeutics Corporation Method of diagnosing and treating asthma
US20150038674A1 (en) * 2013-08-05 2015-02-05 Bayrak Bertan Boran Use of glp-2 analogues in pulmonary diseases for therapeutic purpose

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748A (en) * 1844-09-17 Improvement in ratoon and cane cutters
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
FR2674434B1 (fr) * 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
US5336503A (en) * 1992-03-31 1994-08-09 Daiichi Pharmaceutical Co., Ltd. Anti-peptic ulcer agent
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
ES2134928T3 (es) * 1993-02-19 1999-10-16 Asahi Chemical Ind Derivado de benzotiazolsulfonamida, procedimiento de produccion y aplicacion del mismo.
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
EP0956865B2 (en) * 1996-08-12 2010-08-18 Mitsubishi Tanabe Pharma Corporation MEDICINES COMPRISING Rho KINASE INHIBITOR
CA2302782A1 (en) * 1997-09-19 1999-03-25 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
AU4990599A (en) * 1998-07-14 2000-02-07 Brigham And Women's Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
EP1311663B1 (en) * 2000-08-15 2007-05-30 Immunex Corporation Claudin polypeptides

Also Published As

Publication number Publication date
US20050019314A1 (en) 2005-01-27
FR2833840A1 (fr) 2003-06-27
CA2470442A1 (fr) 2003-07-03
TW200305447A (en) 2003-11-01
AU2002364679A1 (en) 2003-07-09
AR038042A1 (es) 2004-12-22
WO2003053422A2 (fr) 2003-07-03
UY27589A1 (es) 2003-05-30
US20030125321A1 (en) 2003-07-03
EP1455767A2 (fr) 2004-09-15
PE20030853A1 (es) 2003-10-28
AU2002364679A8 (en) 2003-07-09
SV2003001439A (es) 2003-11-04
WO2003053422A3 (fr) 2004-04-15
FR2833840B1 (fr) 2010-06-18

Similar Documents

Publication Publication Date Title
IL181740A0 (en) THERAPEUTIC AGENTS TARGETING THE NCca-atp CHANNEL AND METHODS OF USE THEREOF
ECSP088283A (es) Compuestos de piridina 5- (fenilisoxazoliletoxi) -triazol- 3-ilo substituidos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
IS9028A (is) Ný efnablanda
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
PA8586001A1 (es) Derivados de indol útiles para el tratamiento de enfermedades
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
CY1113094T1 (el) Ανοσοσφαιρινες κατευθυνομενες εναντι nogo
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
IL181826A0 (en) Therapeutic agents targeting the ncca-atp channel and methods of use thereof
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
DOP2007000015A (es) Usos terapéuticos de inhibidores de rtp801
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
WO2003072593A3 (en) Bone targeting peptides
DK1926483T3 (da) Behandling af autoimmune sygdomme
BR0117009A (pt) Composiçoes para utilização no tratamento de distúrbios associados a ige
HN2003000080A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
PA8562701A1 (es) Metodos y composiciones para el tratamiento de patologias respiratorias
UY29417A1 (es) Agentes endoparasiticidas
WO2008105088A1 (ja) 脊髄損傷治療薬剤
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
DK1988909T3 (da) Anvendelse af polyethylenglycol til inflammationsbeslægtede topiske lidelser eller sygdomme og sårheling
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.
GT200800066A (es) Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento.
AR055107A1 (es) Furoato de n-{2-[((2s)-3-{[1-(4-clorobencil)piperidin-4-il]amino}-2-hidroxi-2-metilpropil)oxi]-4-hidroxifenil} acetamida,composiciones farmaceuticas que los contienen y usos para tratar afecciones o enfermedades donde actuan como moduladores del receptor de quimioquina 1(ccr1)